Gritstone bio, Inc. Common Stock
GRTS
GRTS was delisted on the 21st of October, 2024.
90 hedge funds and large institutions have $129M invested in Gritstone bio, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 33 increasing their positions, 20 reducing their positions, and 15 closing their positions.
85% more call options, than puts
Call options by funds: $1.79M | Put options by funds: $969K
65% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 20
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 15
1% less funds holding
Funds holding: 91 → 90 (-1)
15% less capital invested
Capital invested by funds: $151M → $129M (-$22.3M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$2.67M |
| 2 |
Millennium Management
New York
|
+$1.81M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.36M |
| 4 |
Jane Street
New York
|
+$948K |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$910K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AG
Artal Group
Luxembourg
|
-$6.4M |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$1.16M |
| 3 |
Morgan Stanley
New York
|
-$457K |
| 4 |
Two Sigma Investments
New York
|
-$351K |
| 5 |
6CM
683 Capital Management
New York
|
-$213K |
GRTS Hedge Fund Activity: Q1 2023 in Review
90 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Gritstone bio, Inc. Common Stock (GRTS) for Q1 2023, worth a combined $129M — down 15% from $151M a quarter earlier.
Fund positioning in GRTS was balanced in Q1 2023: 15 funds opened new positions, 15 closed out, 33 added to existing stakes and 20 trimmed.
The largest buyer was Bank of America, adding an estimated $2.67M. The largest seller was Artal Group, exiting entirely with an estimated $6.4M sold.
- 90 institutional investors held Gritstone bio, Inc. Common Stock (GRTS) as of Q1 2023, down from 91 in Q4 2022.
- Funds reported $129M of Gritstone bio, Inc. Common Stock stock for Q1 2023, down 15% quarter-over-quarter.
- 15 funds opened new Gritstone bio, Inc. Common Stock positions in Q1 2023 and 15 closed out, a net change of 0 holders.
- The largest Gritstone bio, Inc. Common Stock buyer in Q1 2023 was Bank of America, an estimated $2.67M added.
- The largest Gritstone bio, Inc. Common Stock seller in Q1 2023 was Artal Group, an estimated $6.4M sold.
Based on aggregated 13F filings for Q1 2023.